Back to Search Start Over

Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.

Authors :
Frijstein MM
Lok C
van Trommel NE
Ten Kate-Booij MJ
Massuger L
van Werkhoven E
Short D
Aguiar X
Fisher RA
Kaur B
Sarwar N
Sebire NJ
Seckl MJ
Source :
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2020 Feb; Vol. 127 (3), pp. 389-395. Date of Electronic Publication: 2019 Dec 20.
Publication Year :
2020

Abstract

Objective: Presence of lung metastases in low-risk gestational trophoblastic neoplasia (GTN) is generally considered not to influence prognosis. However, in a recent study in the Netherlands, GTN patients with lung metastases had a higher recurrence rate and more disease-specific deaths compared with patients without metastases. The aim of the present study was to validate these findings in a different country.<br />Design: Historical cohort study.<br />Setting: Charing Cross Hospital, United Kingdom.<br />Population: A total of 1040 low-risk GTN patients treated with methotrexate (MTX) between 2002 and 2016 were identified: 65 with lung metastases (group 1) and 975 without metastases (group 2).<br />Methods: Baseline characteristics, MTX resistance, survival and recurrence rates were recorded and compared between both groups.<br />Main Outcome Measures: MTX resistance, recurrence rate and survival.<br />Results: The occurrence of MTX resistance and median number of MTX courses to achieve remission was significantly higher in patients with lung metastases than patients without metastases (60% versus 38.9%, P = 0.001; and nine versus six courses, P < 0.001). All choriocarcinoma patients (n = 4) with lung metastases developed MTX resistance. The recurrence rate was also higher in group I (9.2% versus 2.7%; P = 0.012). Disease-specific survival was 100% in both groups.<br />Conclusions: The presence of lung metastases at the start of MTX therapy is associated with increased incidence of MTX resistance and recurrence in low-risk GTN without affecting overall survival, which remains 100%. However, individuals with low-risk choriocarcinoma with lung metastases are likely to become resistant to MTX and primary multi-agent chemotherapy should be considered.<br />Tweetable Abstract: The presence of lung metastases appears to increase the risk of recurrence in low-risk GTN, but does not affect overall cure rates and survival.<br /> (© 2019 Royal College of Obstetricians and Gynaecologists.)

Details

Language :
English
ISSN :
1471-0528
Volume :
127
Issue :
3
Database :
MEDLINE
Journal :
BJOG : an international journal of obstetrics and gynaecology
Publication Type :
Academic Journal
Accession number :
31794098
Full Text :
https://doi.org/10.1111/1471-0528.16036